You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

recurrent small cell lung cancer (SCLC)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Relapsed Small Cell Lung Cancer Trial in Beijing (Irinotecan HCl liposome Injection, Topotecan)

Not yet recruiting
  • Relapsed Small Cell Lung Cancer
  • Irinotecan hydrochloride liposome Injection
  • Topotecan
  • Beijing, China
    Cancer Hospital, Chinese Academy of Medical Sciences
Nov 7, 2023

Small-cell Lung Cancer, Relapsed Small Cell Lung Cancer, Recurrent Small Cell Lung Cancer Trial in Kissimmee, Tampa (Nivolumab,

Recruiting
  • Small-cell Lung Cancer
  • +2 more
  • Kissimmee, Florida
  • +1 more
Nov 2, 2022

Extensive Stage Small Cell Lung Carcinoma, Lung Adenocarcinoma, Recurrent Non-Small Cell Lung Carcinoma Trial in Scottsdale,

Recruiting
  • Extensive Stage Small Cell Lung Carcinoma
  • +7 more
  • Scottsdale, Arizona
  • +1 more
Jun 27, 2022

Lung Cancer, SCLC Trial in United States (Nivolumab, Plinabulin, Ipilimumab)

Recruiting
  • Lung Cancer
  • SCLC
  • Duarte, California
  • +7 more
Jan 18, 2023

Small Cell Lung Cancer Trial in New Haven (Combination immunotherapy with Ipilimumab and Nivolumab)

Active, not recruiting
  • Small Cell Lung Cancer
  • Combination immunotherapy with Ipilimumab and Nivolumab
  • New Haven, Connecticut
    Yale University, Yale Cancer Center
Apr 21, 2022

SCLC Trial in United States (Nivatrotamab)

Terminated
  • SCLC
  • Tampa, Florida
  • +6 more
Jul 11, 2022

Small Cell Lung Cancer Recurrent Trial in Goyang-si (Atezolizumab)

Recruiting
  • Small Cell Lung Cancer Recurrent
  • Goyang-si, Gyeonggi-do, Korea, Republic of
    National Cancer Center
Apr 4, 2022

Metastatic Malignant Solid Tumor, Recurrent Lung Small Cell Carcinoma, Recurrent Malignant Solid Tumor Trial in United States

Terminated
  • Metastatic Malignant Solid Neoplasm
  • +8 more
  • Los Angeles, California
  • +13 more
Oct 7, 2022

SCLC, Recurrent Trial in Seoul (Durvalumab+AZD2811 to SCLC patients)

Terminated
  • SCLC, Recurrent
  • Durvalumab+AZD2811 to SCLC patients
  • Seoul, Gangnam-gu, Korea, Republic of
    Samsung Medical Center
Feb 8, 2022

SCLC, Malignant Melanoma, Sarcoma Trial (GD2-SADA:177Lu-DOTA Complex)

Not yet recruiting
  • SCLC
  • +2 more
  • GD2-SADA:177Lu-DOTA Complex
  • (no location specified)
May 4, 2022

Small Cell Lung Cancer Trial in Saint Louis (AL8326 low dose group, AL8326 middle dose group, AL8326 high dose group)

Recruiting
  • Small Cell Lung Cancer
  • AL8326 low dose group
  • +2 more
  • Saint Louis, Missouri
    Siteman cancer center, Washington University
Nov 1, 2022

Small-cell Lung Cancer, Small Cell Lung Carcinoma, Small Cell Lung Cancer Extensive Stage Trial in Worldwide (KRT-232)

Recruiting
  • Small-cell Lung Cancer
  • +3 more
  • Fort Myers, Florida
  • +29 more
Jun 15, 2022

Outcomes ofBrazilian Cohort of Previously Untreated Extensive

Not yet recruiting
  • Extensive-stage Small-cell Lung Cancer
  • Observational study
  • (no location specified)
Aug 24, 2023

Molecular Analysis and Treatment Options of SCLC

Recruiting
  • Small-cell Lung Cancer
  • +4 more
  • Shanghai, China
    Shanghai Chest Hospital
Jul 6, 2023

Extensive Stage Small Cell Lung Cancer (ES-SCLC) Trial (HS-20093)

Not yet recruiting
  • Extensive Stage Small Cell Lung Cancer (ES-SCLC)
  • (no location specified)
Sep 19, 2023

Molecular Subtyping of Extensive Stage Small Cell Lung Cancer

Recruiting
  • SCLC,Extensive Stage
  • PD-(L)1 antibody immunotherapy
  • Beijing, Beijing, China
    Peking University Cancer Hospital & Institute
Jul 3, 2023

Limited-stage Small Cell Lung Cancer (LS-SCLC) Trial in Jinan (Tifcemalimab injection, toripalimab injection, Placebo for

Not yet recruiting
  • Limited-stage Small Cell Lung Cancer (LS-SCLC)
  • Tifcemalimab injection
  • +3 more
  • Jinan, Shandong, China
    Shandong Cancer Hospital & Institute
Oct 18, 2023

Small Cell Lung Cancer Extensive Stage Trial (quaratusugene ozeplasmid, atezolizumab)

Not yet recruiting
  • Small Cell Lung Cancer Extensive Stage
  • quaratusugene ozeplasmid
  • atezolizumab
  • (no location specified)
Jan 19, 2023

Extensive Small Cell Lung Cancer Trial in Jinan (Adebelizumab+Carboplatin+Etoposide+Concurrent Radiotherapy)

Recruiting
  • Extensive Small Cell Lung Cancer
  • Adebelizumab+Carboplatin+Etoposide+Concurrent Radiotherapy
  • Jinan, Shan Dong, China
    The First Affiliated Hospital of Shandong First Medical Universi
Nov 6, 2023

HRD Cancer, SCLC, Advanced Solid Tumors Trial run by the NCI (Berzosertib, Sacituzumab Govitecan)

Recruiting
  • HRD Cancer
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 20, 2023

Extensive-stage Small-cell Lung Cancer Trial (Trilaciclib, Placebo, Topotecan)

Not yet recruiting
  • Extensive-stage Small-cell Lung Cancer
  • (no location specified)
May 22, 2023

Small Cell Lung Cancer Trial (SC0245, Irinotecan)

Not yet recruiting
  • Small Cell Lung Cancer
  • (no location specified)
Feb 7, 2023

Extensive Stage Lung Small Cell Carcinoma, Stage IV Lung Cancer Trial in Nashville (drug, biological, radiation, procedure)

Not yet recruiting
  • Extensive Stage Lung Small Cell Carcinoma
  • Stage IV Lung Cancer
  • Nashville, Tennessee
    Vanderbilt University/Ingram Cancer Center
Oct 25, 2023

Small Cell Lung Cancer Extensive Stage Trial in Jinan, Tianjin, Zhengzhou (IN10018, Tislelizumab, Carboplatin)

Not yet recruiting
  • Small Cell Lung Cancer Extensive Stage
  • Jinan, China
  • +2 more
Sep 10, 2023

Extensive Stage Lung Small Cell Carcinoma, Limited Stage Lung Small Cell Carcinoma, Platinum-Resistant Lung Small Cell Carcinoma

Recruiting
  • Extensive Stage Lung Small Cell Carcinoma
  • +3 more
  • Biopsy
  • +4 more
  • Los Angeles, California
  • +8 more
Jan 31, 2023